14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Sep 02, 2020 $5.07 $5.20 $5.02 $5.15 179 172
Sep 01, 2020 $5.12 $5.19 $4.94 $5.14 133 204
Aug 31, 2020 $5.15 $5.19 $5.05 $5.14 135 929
Aug 28, 2020 $5.01 $5.18 $4.91 $5.17 87 140
Aug 27, 2020 $5.20 $5.20 $4.87 $5.03 132 318
Aug 26, 2020 $5.34 $5.37 $5.12 $5.20 105 343
Aug 25, 2020 $5.19 $5.39 $5.12 $5.34 98 226
Aug 24, 2020 $5.60 $5.64 $5.09 $5.15 194 745
Aug 21, 2020 $5.52 $5.55 $5.40 $5.53 85 966
Aug 20, 2020 $5.47 $5.62 $5.39 $5.51 208 937
Aug 19, 2020 $5.78 $5.86 $5.46 $5.53 156 840
Aug 18, 2020 $5.87 $5.87 $5.64 $5.76 91 401
Aug 17, 2020 $5.80 $5.92 $5.71 $5.87 1 142 300
Aug 14, 2020 $5.56 $5.84 $5.41 $5.77 242 545
Aug 13, 2020 $5.70 $5.70 $5.45 $5.60 158 311
Aug 12, 2020 $5.75 $5.77 $5.56 $5.64 136 031
Aug 11, 2020 $5.91 $5.93 $5.63 $5.72 196 959
Aug 10, 2020 $5.57 $5.94 $5.50 $5.90 190 512
Aug 07, 2020 $5.28 $5.59 $5.28 $5.52 301 103
Aug 06, 2020 $5.54 $5.54 $5.25 $5.35 183 371
Aug 05, 2020 $5.42 $5.56 $5.37 $5.50 180 296
Aug 04, 2020 $5.34 $5.43 $5.26 $5.34 127 567
Aug 03, 2020 $5.31 $5.48 $5.24 $5.35 186 776
Jul 31, 2020 $5.31 $5.45 $5.07 $5.28 222 290
Jul 30, 2020 $5.24 $5.36 $5.15 $5.32 170 283
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT